{"database": "lobbying", "table": "lobbying_activities", "rows": [[2599224, "3de3dc87-c154-4d42-9564-7c81113d280f", "Q1", "DESIMONE CONSULTING, LLC", 400931695, "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)", 2021, "first_quarter", "SCI", "Issues related to the development of new medical therapies including patient access and pricing.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2021-04-17T13:18:59.457000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2599224"], "units": {}, "query_ms": 0.5795640026917681, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}